A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis

This study has been completed.
Sponsor:
Collaborator:
Vigconic (International) Ltd.
Information provided by:
Hospital Authority, Hong Kong
ClinicalTrials.gov Identifier:
NCT00562783
First received: November 20, 2007
Last updated: October 22, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2006
  Estimated Primary Completion Date: No date given